SCHEMBL16977208

SCHEMBL16977208

Cc1c2c(c(Nc3ccc(O)cc3)n1Cc1ccc(-n3ccnc3)cc1)C(=O)NC1=N[C@H]3CCCC[C@H]3N12

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 9/20 0.34
▸ TNIK Q9UKE5 1/20 0.34
▸ ENPP2 Q13822 1/20 0.33
▸ MKNK1 Q9BUB5 1/20 0.33
▸ MKNK2 Q9HBH9 1/20 0.33
▸ MCHR1 Q99705 1/20 0.33
▸ PDE4A P27815 6/20 0.33
▸ PDE2A O00408 2/20 0.33
▸ PDE8A O60658 2/20 0.33
▸ PDE3B Q13370 2/20 0.33
▸ PDE11A Q9HCR9 2/20 0.33
▸ PDE7B Q9NP56 2/20 0.33
▸ PDE10A Q9Y233 2/20 0.33
▸ KAT2B Q92831 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.32
▸ PDE9A O76083 1/20 0.32
▸ LSS P48449 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13333214 0.86 PDE4A (0.44) PDE5APDE4APDE2APDE8APDE3B
SCHEMBL16977207 0.84 PDE5A (0.36) PDE5APDE4APDE2APDE8APDE3B
SCHEMBL12281246 0.78 PDE4A (0.47) PDE5APDE4APDE2APDE8APDE3B
SCHEMBL15745628 0.71 PDE4A (0.48) PDE5APDE4APDE2APDE8APDE3B
SCHEMBL12281371 0.70 PDE4A (0.48) PDE5APDE4APDE2APDE8APDE3B
SCHEMBL798740 0.70 PDE4A (0.59) PDE5APDE4APDE2APDE8APDE3B
SCHEMBL16977213 0.68 SYK (0.51) —
SCHEMBL2362682 0.65 PDE4A (0.54) PDE5APDE4APDE2APDE8APDE3B
SCHEMBL12281182 0.64 PDE4A (0.47) PDE5APDE4APDE2APDE8APDE3B
SCHEMBL12281180 0.61 PDE4A (0.64) PDE5APDE4APDE2APDE8APDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2358204-B1 4,5,7,8-tetrahydro-4-oxo-2H-imidazo[1,2-a]pyrrolo[3,4-e]pyrimidine compounds as PDE1 inhibitors. INTRA CELLULAR THERAPIES INC (US) 2015-08-05 — — EP disclosed
Send feedback